Xcout IntelSign inSubscribe

ChromaCode, Inc. competitors & alternatives

DiagnosticsUnited States

The 12 closest competitors and alternatives to ChromaCode, Inc. among diagnostics companies — ranked by similarity to what ChromaCode, Inc. actually does, not by market-cap band.

12Competitors listed

Subscribe to see ChromaCode, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About ChromaCode, Inc.

ChromaCode, Inc. is a for-profit company located in Carlsbad, California, offering HDPCR multiplexing technology solutions.

ChromaCode, Inc. at a glance

ChromaCode, Inc. is a diagnostics company headquartered in United States. Its most recent funding round raised $3.8M in January 2025. Xcout tracks 4 named people at ChromaCode, Inc., including Paul Flook (Chief Executive Officer).

ChromaCode, Inc. leadership

  • Paul FlookChief Executive Officer
  • Paul FlookExecutive Officer
  • Aditya RajagopalDirector
  • Justin KleinDirector

ChromaCode, Inc. funding rounds

The 4 most recent:

DateRoundAmountInvestors
SEC Form D filing$3.8M—
SEC Form D filing$38M—
Series C$10M1 named
SEC Form D filing$38.6M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 ChromaCode, Inc. competitors

Ranked by semantic similarity — how close each company is to ChromaCode, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

10x Genomics, Inc.TXG · BiotechPleasanton, United States
64% matchPublic

Biotech

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Market cap$7.1B
Employees1,306
10x Genomics, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of ChromaCode, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for ChromaCode, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →